Deutsche Bank Ag\ Cullinan Oncology, Inc. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Cullinan Oncology, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 560,873 shares of CGEM stock, worth $6.14 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

560,873

Previous 555,067 1.05%

Holding current value

$6.14 Million

Previous $9.68 Million 3.01%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$16.03 - $20.86 $93,070 - $121,113	5,806 Added 1.05%	560,873 $9.39 Million
Q2 2024 Aug 14, 2024	BUY	$15.63 - $29.35 $90,513 - $169,965	5,791 Added 1.05%	555,067 $9.68 Million
Q1 2024 May 15, 2024	BUY	$10.17 - $19.02 $37,547 - $70,221	3,692 Added 0.68%	549,276 $9.36 Million
Q4 2023 Feb 14, 2024	BUY	$7.89 - $10.23 $4.27 Million - $5.53 Million	540,967 Added 11716.85%	545,584 $5.56 Million
Q3 2023 Nov 09, 2023	SELL	$9.05 - $11.72 $33,267 - $43,082	-3,676 Reduced 44.33%	4,617 $41,000
Q2 2023 Aug 14, 2023	SELL	$8.8 - $13.4 $67,496 - $102,778	-7,670 Reduced 48.05%	8,293 $89,000
Q1 2023 May 15, 2023	BUY	$10.2 - $11.91 $37,270 - $43,519	3,654 Added 29.69%	15,963 $163,000
Q4 2022 Feb 13, 2023	BUY	$9.72 - $13.62 $1,982 - $2,778	204 Added 1.69%	12,309 $129,000
Q3 2022 Nov 14, 2022	SELL	$11.82 - $15.42 $23,557 - $30,732	-1,993 Reduced 14.14%	12,105 $155,000
Q2 2022 Aug 11, 2022	SELL	$7.31 - $13.55 $1,929 - $3,577	-264 Reduced 1.84%	14,098 $181,000
Q1 2022 May 13, 2022	SELL	$10.47 - $16.75 $17,401 - $27,838	-1,662 Reduced 10.37%	14,362 $150,000
Q4 2021 Feb 11, 2022	BUY	$15.36 - $25.0 $12,625 - $20,550	822 Added 5.41%	16,024 $247,000
Q3 2021 Nov 04, 2021	BUY	$22.56 - $29.68 $155,257 - $204,257	6,882 Added 82.72%	15,202 $343,000
Q2 2021 Aug 11, 2021	SELL	$24.96 - $41.25 $6,539 - $10,807	-262 Reduced 3.05%	8,320 $214,000
Q1 2021 May 13, 2021	BUY	$28.0 - $53.42 $240,296 - $458,450	8,582 New	8,582 $357,000

Others Institutions Holding CGEM

# of Institutions

146

Shares Held

67.6M

Call Options Held

612K

Put Options Held

118K

View Full List

About Cullinan Oncology, Inc.

Ticker CGEM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,612,200
Market Cap $499M
Description
Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalation and expansion trial for treating patients with ...

More about CGEM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account